Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Shanghai Jiaoda Onlly CoSHSE:600530 +1.83%45 PS Ratio is 10.63 as of Aug. 12, 2026, which is 1% below its 10-year median of 10.74. GuruFocus rates SHSE:600530 with a GF Score™ of 45/100 and a GF Value™ of ¥2.94 (Significantly Overvalued). The stock has 3 warning signs investors should review. Among 952 Drug Manufacturers companies, Shanghai Jiaoda Onlly Co ranks worse than 87.18% on this metric.
The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. As of today, Shanghai Jiaoda Onlly Co's share price is ¥3.90.
Shanghai Jiaoda Onlly Co's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2026 was ¥0.37. Hence, Shanghai Jiaoda Onlly Co's PS Ratio for today is 10.63.
Good Sign:
Shanghai Jiaoda Onlly Co Ltd stock PS Ratio (=10.54) is close to 1-year low of 10.54.
The historical rank and industry rank for Shanghai Jiaoda Onlly Co's PS Ratio or its related term are showing as below:
SHSE:600530'
s PS Ratio Range Over the Past 10 Years
Min: 3.55 Med: 10.74 Max: 24.92
Current: 10.59
During the past 13 years, Shanghai Jiaoda Onlly Co's highest PS Ratio was 24.92. The lowest was 3.55. And the median was 10.74.
SHSE:600530's PS Ratio is ranked worse than 87.18% of 952
companies
in the Drug Manufacturers industry
Industry Median: 2.365
vs SHSE:600530: 10.59
Shanghai Jiaoda Onlly Co Ltd revenue per share has been in decline over the past 3 years.
During the past 12 months, the average Revenue per Share Growth Rate of Shanghai Jiaoda Onlly Co was -19.70% per year.
During the past 3 years, the average Revenue per Share Growth Rate was -5.80% per year.
During the past 5 years, the average Revenue per Share Growth Rate was -0.70% per year.
During the past 10 years, the average Revenue per Share Growth Rate was 2.50% per year.
During the past 13 years, Shanghai Jiaoda Onlly Co's highest 3-Year average Revenue per Share Growth Rate was 8.50% per year. The lowest was -20.70% per year. And the median was 1.80% per year.
Shanghai Jiaoda Onlly Co (SHSE:600530) PS Ratio Explanation
The PS Ratio is an excellent valuation indicator if you want to compare a stock with its historical valuation or with the stocks in the same industry. The PS Ratio works especially well when you want to compare the stock's current valuation with its historical valuation. The PS Ratio is a great valuation tool for evaluating cyclical businesses where the PE Ratio works poorly. It works the best when comparing the current valuation with the historical valuation because over time, a company's profit margin tends to revert to the mean.
When the PS Ratio is applied to the whole stock market, it can be used to evaluate the current market valuation and projected returns. In this case, the price is the total market cap of all stocks that are traded, and sales are the GDP of the country. This is how Warren Buffett estimates the broad market valuation and project future returns.
The PS Ratio does not tell you how cheap or expensive the stock is. It cannot be used to compare companies in different industries. It works better for companies within the same industry because these companies tend to have similar capital structures and profit margins. It works the best when comparing a company with itself in the past.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, Shanghai Jiaoda Onlly Co's PS Ratio, along with its competitors' market caps and PS Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Shanghai Jiaoda Onlly Co PS Ratio vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Shanghai Jiaoda Onlly Co's PS Ratio distribution charts can be found below:
* The bar in red indicates where Shanghai Jiaoda Onlly Co's PS Ratio falls into.
The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. It is a ratio widely used to value stocks and it was first used by Ken Fisher.
Shanghai Jiaoda Onlly Co's Share Price of today is ¥3.90. Shanghai Jiaoda Onlly Co's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥0.37.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
Shanghai Jiaoda Onlly Co (SHSE:600530) has a PS Ratio of 10.63 as of Aug. 12, 2026. Price-to-Sales ratio is the ratio of share price to a company's revenue per share. View historical data on Shanghai Jiaoda Onlly Co and its competitors. This is near median its historical median of 10.74. Over the past decade, Shanghai Jiaoda Onlly Co's PS Ratio has ranged from 3.55 to 24.92. According to the industry distribution chart, Shanghai Jiaoda Onlly Co ranks #830 out of 952 companies in the Drug Manufacturers industry, placing it in the top 87.2%.
Is Shanghai Jiaoda Onlly Co's PS Ratio too high?
Shanghai Jiaoda Onlly Co's current PS Ratio of 10.63 is near median its 10-year median of 10.74. Over the past 10 years, this metric has ranged from a low of 3.55 to a high of 24.92. The Drug Manufacturers industry median PS Ratio is 2.37. Shanghai Jiaoda Onlly Co's value of 10.63 is 349.5% above this industry median. Based on the distribution chart, Shanghai Jiaoda Onlly Co ranks #830 out of 952 companies in the Drug Manufacturers industry, which is in the bottom quartile relative to peers. Overall, Shanghai Jiaoda Onlly Co has a GF Score™ of 45/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Shanghai Jiaoda Onlly Co's PS Ratio compare to ZTS?
According to the Drug Manufacturers industry distribution chart, Shanghai Jiaoda Onlly Co ranks #830 out of 952 companies for PS Ratio. This places Shanghai Jiaoda Onlly Co in the lower half of its industry. The industry median PS Ratio is 2.37. Shanghai Jiaoda Onlly Co's value of 10.63 is 349.5% above this benchmark. Historically, Shanghai Jiaoda Onlly Co's own PS Ratio has ranged from 3.55 to 24.92 over the past decade. While the company's 10-year median is 10.74 vs. the industry median of 2.37, Shanghai Jiaoda Onlly Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PS Ratio for a Drug Manufacturers company?
The median PS Ratio among Drug Manufacturers companies is 2.37, based on 952 companies in the industry. Companies in the top quartile (top 25%) have a PS Ratio significantly above this median, while those in the bottom quartile fall well below. However, PS Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Shanghai Jiaoda Onlly Co's current PS Ratio of 10.63 is 349.5% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PS Ratio mean?
A high PS Ratio can signal that a stock is expensive relative to its fundamentals. Price-to-Sales ratio is the ratio of share price to a company's revenue per share. View historical data on Shanghai Jiaoda Onlly Co and its competitors. For the Drug Manufacturers industry, the median PS Ratio is 2.37 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Shanghai Jiaoda Onlly Co's current PS Ratio is 10.63, which is near median its own 10-year median of 10.74. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Shanghai Jiaoda Onlly Co stock overvalued right now?
Based on GuruFocus' analysis, Shanghai Jiaoda Onlly Co (SHSE:600530) is currently considered Significantly Overvalued. The stock's GF Value™ is ¥2.94, compared to a current price of ¥3.90 — trading 32.7% above its estimated fair value. The current PS Ratio is 10.63, which is near median its 10-year median of 10.74 and 349.5% above the Drug Manufacturers industry median of 2.37. Shanghai Jiaoda Onlly Co's overall GF Score™ is 45/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PS Ratio calculated?
PS Ratio is calculated from a company's financial statements. For Shanghai Jiaoda Onlly Co (SHSE:600530), the current PS Ratio is 10.63 as of Aug. 12, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Shanghai Jiaoda Onlly Co (SHSE:600530) Overvalued in 2026?
Based on GuruFocus' analysis, Shanghai Jiaoda Onlly Co stock appears to be overvalued.
The current stock price of ¥3.90 is trading 32.7% above its estimated GF Value™ of ¥2.94.
GuruFocus considers Shanghai Jiaoda Onlly Co to be Significantly Overvalued.
Key valuation signals for SHSE:600530:
PS Ratio: 10.63 (near median its 10-year median of 10.74)
GF Value™: ¥2.94 vs. price of ¥3.90 (32.7% above fair value)
Industry Position: 349.5% above the Drug Manufacturers median (#830 of 952)
No single metric tells the full story. See the SHSE:600530 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Shanghai Jiaoda Onlly Co Ltd is engaged in producing and distributing healthcare products. The company is also involved in real estate and financial investment. Its main products are biological products and healthcare products.
45GF Score
Get the complete analysis for SHSE:600530
PS Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SHSE:600530 has been successfully added to your 
